Cannabidiol (Epidiolex)

Small molecule

Also known as GWP42003

Approvedregulatory verdict

Evidence outlook

Approved: Epilepsy, Lennox-Gastaut Syndrome, Dravet Syndrome, Developmental and Epileptic Encephalopathies

Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.

track record: Reliable signal

Also approved (2)
US
  • Treatment of seizures associated with tuberous sclerosis complex (TSC) in patients 1 year of age and older
Product first approved 2018Outside this platform's coverageFDA label
EU
  • Epidyolex is indicated for use as adjunctive therapy of seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome (DS), in conjunction with clobazam, for patients 2 years of age and older.
Product first approved 2019EMA

How the evidence outlook works ↗

All registered studies

Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase. Studies where this drug served as another program's comparator, or is merely referenced, are listed separately below.

Phase 3 (16)
Developmental and Epileptic Encephalopathies
NCT04485104 · Jazz Pharmaceuticals
2021-05-19 – 2025-01-28 · Seizure in Participants With Tuberous Sclerosis Complex, Seizure in Participants With Dravet Syndrome, Seizure in Participants With Lennox-Gastaut Syndrome
What this study did
NCT02224703 · Jazz Pharmaceuticals
2015-04-13 – 2018-04-09 · Epilepsy, Dravet Syndrome
What this study did
Epilepsy
NCT05288283 · Jazz Pharmaceuticals
2022-10-31 – 2023-09-28 · Seizures Associated With EMAS
What this study did
NCT02954887 · Jazz Pharmaceuticals
2017-05-12 – 2019-06-13 · Infantile Spasms
What this study did
NCT02953548 · Jazz Pharmaceuticals
2017-04-24 – 2018-05-07 · Infantile Spasms
What this study did
Lennox-Gastaut Syndrome
Other / comorbidity
NCT07148206 · Montefiore Medical Center
2026-10 – 2028-05 · Opioid Use Disorder
What this study did
NCT07123467 · Wayne State University
2025-11-03 – 2027-08-31 · Generalized Anxiety Disorder (GAD), Anxiety Disorders
What this study did
NCT04252586 · Jazz Pharmaceuticals
2020-02-28 – 2021-06-09 · Rett Syndrome, RTT
What this study did
NCT03848832 · Jazz Pharmaceuticals
2019-07-29 – 2021-01-21 · Rett Syndrome, RTT
What this study did
Phase 2/3 (3)
Other / comorbidity
NCT06333041 · Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
2026-04-01 – 2028-12 · Sanfilippo Syndrome, Mucopolysaccharidosis III
What this study did
NCT04387617 · Mayo Clinic
2021-02-15 – 2022-01-31 · Urinary Stone
What this study did
NCT04423341 · Silkiss Eye Surgery
2020-05-20 – 2021-10-01 · Blepharospasm, Blepharospasm, Benign Essential, CBD
What this study did
Phase 2 (31)
Developmental and Epileptic Encephalopathies
NCT02091206 · Jazz Pharmaceuticals
2014-10-22 – 2015-03-09 · Epilepsy, Dravet Syndrome
What this study did
Epilepsy
NCT02607891 · Jazz Pharmaceuticals
2016-11-09 – 2018-10-02 · Epilepsy
What this study did
NCT02564952 · Jazz Pharmaceuticals
2016-03-11 – 2017-06-07 · Epilepsy
What this study did
NCT02565108 · Jazz Pharmaceuticals
2016-01-20 – 2016-07-21 · Epilepsy
What this study did
Other / comorbidity
NCT07564245 · Assistance Publique - Hôpitaux de Paris
2026-05 – 2030-02 · Neurodevelopmental Disorders With Severe Self-injuries
What this study did
NCT06234631 · Chad Brummett
2024-03-13 – 2029-01 · Knee Replacement Surgery, Osteoarthritis, Knee
What this study did
NCT06213233 · Kevin Boehnke
2024-02-12 – 2028-12 · Pain, Chronic
What this study did
NCT07778810 · Johns Hopkins University
2026-09-17 – 2028-07 · Sturge - Weber Syndrome (SWS)
What this study did
NCT06840899 · University of Wisconsin, Madison
2026-02-13 – 2028-05 · Supra-sacral Spinal Cord Injury, Spinal Cord Injury, Urinary Incontinence
What this study did
NCT06731894 · City of Hope Medical Center
2025-10-03 – 2028-01-07 · Breast Carcinoma, Chemotherapy-Induced Peripheral Neuropathy, Colon Carcinoma
What this study did
NCT04992624 · Steven E Harte, PhD
2022-02-22 – 2027-06-30 · Osteoarthritis, Knee, Osteoarthritis of the Knee
What this study did
NCT05066308 · Massachusetts General Hospital
2022-01-04 – 2026-05-01 · Back Pain, Depressive Symptoms
What this study did
NCT04105231 · Lone Baandrup
2021-06-01 – 2026-03-31 · Dual Diagnosis
What this study did
NCT04517799 · University of California, San Diego
2020-06-01 – 2025-12-31 · Autism, Autism Spectrum Disorder
What this study did
NCT04978428 · University of Chicago
2022-04-14 – 2025-11-01 · Obsessive-Compulsive Disorder, Trichotillomania (Hair-Pulling Disorder), Tourette Syndrome, Hoarding Disorder
What this study did
NCT04567784 · Yasmin Hurd
2020-11-12 – 2025-06-18 · Heroin Abuse, Opioid Use Disorder, Substance-Related Disorders, Opioid-Related Disorders
What this study did
NCT05823753 · University of California, San Diego
2023-04-19 – 2024-08-20 · Social Anxiety, Social Anxiety Disorder
What this study did
NCT04745026 · Jazz Pharmaceuticals
2021-05-31 – 2023-12-21 · Autism Spectrum Disorder
What this study did
NCT05651607 · Assistance Publique - Hôpitaux de Paris
2023-09-07 – 2023-11-17 · Hereditary Epidermolysis Bullosa
What this study did
NCT05388058 · Mayo Clinic
2022-06-09 – 2023-07-28 · Chemotherapy-Induced Peripheral Neuropathy, Malignant Solid Neoplasm
What this study did
NCT04447846 · Anne Comi, MD
2019-10-14 – 2022-12-09 · Sturge-Weber Syndrome
What this study did
NCT04982029 · Brigham and Women's Hospital
2022-04-14 – 2022-12-02 · Opioid-use Disorder
What this study did
NCT04192370 · Brigham and Women's Hospital
2020-08-03 – 2021-12-30 · Opioid-use Disorder
What this study did
NCT02818777 · University of Colorado, Denver
2016-10 – 2017-11 · Parkinson's Disease
What this study did
NCT02006628 · Jazz Pharmaceuticals
2014-02-25 – 2015-01-08 · Schizophrenia, Schizophrenia-related Psychotic Disorder
What this study did
NCT01562314 · GW Research Ltd
2012-05-09 – 2014-08-05 · Ulcerative Colitis
What this study did
NCT01491490 · GW Research Ltd
2011-10 – 2012-10 · Schizophrenia
What this study did
NCT01217112 · Jazz Pharmaceuticals
2010-10 – 2012-09 · Dyslipidemias, Diabetes Mellitus, Type 2
What this study did
NCT01284634 · GW Research Ltd
2011-05-03 – 2012-07-13 · Fatty Liver
What this study did
Phase 1/2 (8)
Other / comorbidity
NCT07278505 · Icahn School of Medicine at Mount Sinai
2025-10-29 – 2030-02-28 · Early Life Adversity, Trauma, Stress
What this study did
NCT06381791 · The Methodist Hospital Research Institute
2024-05-24 – 2027-12-30 · Shoulder Osteoarthritis, Rotator Cuff Injuries
What this study did
NCT06930703 · Icahn School of Medicine at Mount Sinai
2025-04-03 – 2027-02-01 · Sickle Cell Disease
What this study did
NCT05132699 · The University of Texas Health Science Center at San Antonio
2022-04-04 – 2023-06-30 · Posttraumatic Stress Disorder, Stress Disorders, Post-Traumatic
What this study did
NCT04642404 · The University of Texas Health Science Center at San Antonio
2021-03-01 – 2023-03-13 · Odontalgia, Toothache
What this study did
NCT04238754 · Johns Hopkins University
2020-11-01 – 2022-06-30 · Opioid Withdrawal, Opioid Craving, Opioid Use Disorder
What this study did
NCT02332655 · Anne Comi, MD
2014-12 – 2021-04 · Sturge-Weber Syndrome
What this study did
NCT03904849 · Medical University of South Carolina
2019-10-01 – 2020-04-30 · Alcohol Use Disorder
What this study did
Phase 1 (18)
Epilepsy
NCT07233239 · Jazz Pharmaceuticals
2025-11-26 – 2027-11-29 · Focal Seizures
What this study did
NCT04721691 · Northwell Health
2021-03-10 – 2024-01-17 · Electrical Status Epilepticus of Slow-Wave Sleep
What this study did
NCT02700412 · University of Alabama at Birmingham
2015-04 – 2019-08-08 · Epilepsy, Seizures
What this study did
NCT02695537 · University of Alabama at Birmingham
2015-04 – 2019-02-27 · Epilepsy, Seizures
What this study did
Other / comorbidity
NCT07001930 · Johns Hopkins University
2025-08-25 – 2029-09-01 · CBD, Stress, Nicotine Dependence, Tobacco Smoking
What this study did
NCT07886606 · Yale University
2021-12-08 – 2027-12-31 · Chronic Pain, Opioid Use Disorder
What this study did
NCT07918469 · Avata Biosciences Holdings Ltd
2026-10-20 – 2027-04-30 · Focal Onset Seizure
What this study did
NCT07462559 · Helsinki University Central Hospital
2026-03-04 – 2026-12-31 · Drug Drug Interaction
What this study did
NCT04878627 · University of California, San Diego
2022-01-20 – 2026-06 · Anorexia Nervosa
What this study did
NCT05672342 · City of Hope Medical Center
2024-07-06 – 2025-10-31 · Breast Carcinoma, Chemotherapy-Induced Peripheral Neuropathy, Colon Carcinoma
What this study did
NCT05490511 · Indiana University
2022-10-31 – 2025-08-31 · CBD, Transplant Complication, Kidney Disease, Chronic
What this study did
NCT04587791 · Yale University
2021-12-08 – 2025-03-19 · Chronic Pain, Opioid Use Disorder
What this study did
NCT06192589 · Food and Drug Administration (FDA)
2024-02-08 – 2024-09-06 · Cannabidiol, Drug Induced Liver Injury, Drug Interaction
What this study did
NCT04231643 · University of California, San Diego
2021-09-01 – 2023-11-28 · Bipolar Disorder
What this study did
NCT05269706 · Yasmin Hurd
2022-05-18 – 2023-02-16 · Opioid Use Disorder
What this study did
NCT05023070 · Icahn School of Medicine at Mount Sinai
2021-07-22 – 2023-02-16 · Healthy
What this study did
NCT04428203 · Zin W Myint
2020-08-03 – 2021-08-20 · Prostate Cancer Recurrent, Prostate Cancer, Prostate Adenocarcinoma
What this study did
NCT03102918 · Mclean Hospital
2016-02-20 – 2017-08-30 · Cannabis Use Disorder
What this study did
Phase 4 (11)
Developmental and Epileptic Encephalopathies
NCT06924827 · Elizabeth Donner
2027-01-01 – 2029-06 · Dravet Syndrome (DS), Lennox-Gastaut Syndrome (LGS)
What this study did
NCT05044819 · Jazz Pharmaceuticals
2021-07-07 – 2028-03-31 · Lennox Gastaut Syndrome, Dravet Syndrome, Tuberous Sclerosis Complex
What this study did
Epilepsy
NCT05324449 · Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
2022-04-05 – 2025-05-05 · Anxiety, Epilepsy
What this study did
NCT04899050 · University of South Florida
2021-07-30 – 2023-05-27 · Study the Efficacy of Epidiolex for Typical Absence Seizures
What this study did
Lennox-Gastaut Syndrome
NCT07728097 · Jazz Pharmaceuticals
2026-11-18 – 2028-12-28 · Lennox-Gastaut Syndrome
What this study did
NCT04133480 · Jazz Pharmaceuticals
2020-10 – 2021-12 · Lennox-Gastaut Syndrome
What this study did
Other / comorbidity
NCT05649059 · Massachusetts Institute of Technology
2025-07-10 – 2027-05 · Phobia, Social
What this study did
NCT05864846 · Jazz Pharmaceuticals
2023-06-29 – 2026-04-06 · Tuberous Sclerosis Complex Associated Neuropsychiatric Disease
What this study did
NCT04749628 · Hospital for Special Surgery, New York
2022-11-02 – 2025-01-08 · Pain, Postoperative, Opioid Use, Knee Osteoarthritis
What this study did
NCT04603391 · University of Florida
2021-02-25 – 2021-12-31 · Drug Interaction
What this study did
NCT03891264 · Massachusetts General Hospital
2019-11-13 – 2020-11-23 · Back Pain, Low
What this study did
Used as active comparator (5)

Other programs' studies in which this drug was the registered active-comparator arm: a marker of standard-of-care status, not evidence of this drug's own progression.

Phase 2 (1)
Other / comorbidity
NCT05942911 · Incannex Healthcare Ltd
2023-11-22 – 2025-10-28 · Rheumatoid Arthritis
What this study did
Phase 1 (4)
Other / comorbidity
NCT07186283 · NW PharmaTech Ltd
2025-09-22 – 2025-12-10 · PK in Healthy Volunteers
What this study did
NCT06578455 · dsm-firmenich Switzerland AG
2024-08-30 – 2024-12-16 · CBD Pharmacokinetics, Healthy Participants
What this study did
NCT04790136 · SocraTec R&D GmbH
2021-03-17 – 2021-05-12 · Comparative Bioavailability
What this study did
NCT02051387 · Central Institute of Mental Health, Mannheim
2013-01 – 2017-08 · Schizophrenia
What this study did
Studied as part of a combination product (1)

Studies of a fixed-dose combination that contains this drug. The combination is the product under test, so these are that product's evidence rather than this one's; the link is kept because the drug really was administered.

Phase 2/3 (1)
Other / comorbidity
NCT04989413 · Hospital Israelita Albert Einstein
2022-10-18 – 2025-02-20 · Chronic Migraine, Headache, Overuse Headache Medication
What this study did
Appears in other studies (204)

Studies that reference this drug without giving it an intervention arm of its own: other formulations' programs, background therapy, or registry-search bleed.

Phase 3 (17)
Developmental and Epileptic Encephalopathies
NCT04611438 · Yonsei University
2020-03-30 – 2021-06 · Dravet Syndrome, Lennox Gastaut Syndrome
What this study did
NCT02318563 · INSYS Therapeutics Inc
2017-12-30 – 2018-06-17 · Dravet Syndrome
What this study did
Epilepsy
NCT02783092 · Antonio Waldo Zuardi
2019-01-09 – 2024-09-25 · Epilepsy
What this study did
NCT03421496 · Radius Pharmaceuticals, Inc.
2018-09-05 – 2019-05-29 · Infantile Spasm
What this study did
NCT02318602 · INSYS Therapeutics Inc
2016-01-08 – 2017-06-22 · Seizures
What this study did
Lennox-Gastaut Syndrome
NCT02318537 · INSYS Therapeutics Inc
2017-12-30 – 2018-06-30 · Lennox-Gastaut Syndrome
What this study did
Other / comorbidity
NCT05867849 · University of British Columbia
2023-10-15 – 2030-12 · Bipolar Disorder
What this study did
NCT07245238 · Khon Kaen University
2025-11-05 – 2028-12 · Mediciine, Systemic Sclerosis (SSc), Intervention Study
What this study did
NCT05840822 · Avecho Biotechnology
2024-05-16 – 2027-12 · Insomnia
What this study did
NCT06940674 · Icahn School of Medicine at Mount Sinai
2025-06-13 – 2027-08-15 · Opioid Use Disorder (OUD)
What this study did
NCT06708299 · Cardiol Therapeutics Inc.
2025-04-07 – 2026-10-21 · Recurrent Pericarditis
What this study did
NCT04977986 · Harmony Biosciences Management, Inc.
2021-09-13 – 2025-08-29 · Fragile X Syndrome, Fragile X Syndrome (FXS)
What this study did
NCT06099171 · Humanitas Clinical and Research Center
2024-02-01 – 2025-03-01 · Neck Pain
What this study did
NCT04527003 · Milton S. Hershey Medical Center
2020-12-04 – 2024-06-26 · Endometriosis, CBD, Pelvic Pain
What this study did
NCT04729179 · Marius Henriksen
2021-03-01 – 2024-02-14 · Fibromyalgia
What this study did
NCT03549819 · McMaster University
2021-12-15 – 2024-02 · Generalized Anxiety Disorder, Social Anxiety Disorder, Panic Disorder, Agoraphobia
What this study did
NCT04271917 · University of Tennessee
2020-02-24 – 2022-03-31 · Pain, Acute
What this study did
Phase 2/3 (13)
Other / comorbidity
NCT07148843 · Johns Hopkins University
2026-10-21 – 2030-10-31 · Alcohol Use Disorder (AUD), Withdrawal From Addictive Substance; Detoxification, Craving
What this study did
NCT05020028 · NYU Langone Health
2022-06-22 – 2027-09 · Knee Arthritis
What this study did
NCT05613608 · University of Colorado, Denver
2023-04-30 – 2027-04 · Alcohol Use Disorder
What this study did
NCT03802799 · Zynerba Pharmaceuticals, Inc.
2018-11-09 – 2026-06-30 · Fragile X Syndrome
What this study did
NCT06514066 · Hospital Pengajar Universiti Putra Malaysia
2024-09-01 – 2025-10-01 · Dementia, Vascular, Dementia, Mixed
What this study did
NCT04613102 · Elena Pope
2020-08-01 – 2022-12-30 · Epidermolysis Bullosa, Pain, Itch
What this study did
NCT04615949 · Cardiol Therapeutics Inc.
2021-04-30 – 2022-11-30 · COVID-19, Cardiovascular Diseases, Cardiovascular Risk Factor
What this study did
NCT05283161 · FG Brasil LTDA
2022-04-15 – 2022-11-20 · Fibromyalgia
What this study did
NCT04467918 · University of Sao Paulo
2020-07-06 – 2021-11-16 · SARS-CoV2
What this study did
NCT04504877 · University of Sao Paulo
2020-06-16 – 2020-12-16 · Covid19, Burn Out, Post Traumatic Stress Disorder
What this study did
NCT03614663 · Zynerba Pharmaceuticals, Inc.
2018-06-12 – 2020-06-14 · Fragile X Syndrome
What this study did
NCT03310593 · Hospital de Clinicas de Porto Alegre
2017-11-01 – 2020-03-24 · Bipolar Disorder, Bipolar Depression, Bipolar Affective Disorder
What this study did
NCT03467620 · University of Illinois at Chicago
2018-07 – 2019-07 · Crohn Disease, Inflammatory Bowel Diseases, Cannabis
What this study did
Phase 2 (83)
Epilepsy
NCT05803434 · Meyer Children's Hospital IRCCS
2024-03-14 – 2026-12-01 · Epilepsy, Rare Diseases
What this study did
NCT06523725 · Dr. Paul Lyons
2024-11-01 – 2025-04-15 · Post-traumatic Epilepsy
What this study did
NCT03355300 · Radius Pharmaceuticals, Inc.
2018-02-20 – 2019-06-28 · Childhood Absence Epilepsy
What this study did
NCT03336242 · Radius Pharmaceuticals, Inc.
2017-12-29 – 2019-05-29 · Childhood Absence Epilepsy
What this study did
NCT02551731 · INSYS Therapeutics Inc
2016-01-27 – 2016-09-06 · Spasms, Infantile
What this study did
Other / comorbidity
NCT07527338 · University of Colorado, Boulder
2026-07-01 – 2031-04-01 · Sleep, Alcohol Misuse
What this study did
NCT07279558 · University of Colorado, Denver
2026-04-21 – 2029-08-31 · Alcohol Use Disorder
What this study did
NCT05822362 · University of Colorado, Denver
2024-01-19 – 2029-04 · Mild Cognitive Impairment
What this study did
NCT05269459 · University of Nebraska
2022-12-01 – 2029-04 · PTSD
What this study did
NCT06107062 · University of Colorado, Boulder
2024-07-26 – 2029-03-31 · Cannabis Use Disorder
What this study did
NCT07549256 · Regionshospital Nordjylland
2026-06-12 – 2029-01 · Metastatic Castration Resistant Prostate Cancer (mCRPC)
What this study did
NCT06845124 · Central Institute of Mental Health, Mannheim
2025-07-22 – 2028-09-30 · Alcohol Addiction, Alcoholism
What this study did
NCT06290063 · University of Colorado, Boulder
2024-05-01 – 2028-08-31 · Sleep, Anxiety, Depression, Pain
What this study did
NCT07624279 · American Society of Pain and Neuroscience, Inc.
2026-06-01 – 2028-07-01 · Persistent Post Traumatic Headache
What this study did
NCT06266611 · University of Colorado, Boulder
2024-09-16 – 2028-06-30 · Sleep, Anxiety, Depression, Pain
What this study did
NCT06569394 · University of Colorado, Denver
2024-12-09 – 2028-06-30 · Cannabis Use Disorder
What this study did
NCT06575751 · University of Colorado, Denver
2024-12-04 – 2028-06-30 · Cannabis Use Disorder
What this study did
NCT07224932 · University of Colorado, Denver
2026-11-01 – 2028-06-01 · Restless Leg Syndrome
What this study did
NCT07638189 · University of Tennessee
2026-07-01 – 2028-03-30 · Osteoarthitis
What this study did
NCT06994520 · Khon Kaen University
2025-05-01 – 2027-12-31 · Chronic Pruritus, Eczema, Nummular Eczema, Atopic Dermatitis, Prurigo Nodularis
What this study did
NCT02926859 · Central Institute of Mental Health, Mannheim
2017-04-08 – 2027-12 · Schizophrenia
What this study did
NCT06448923 · Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
2025-06-01 – 2027-06 · Fracture
What this study did
NCT06538389 · City of Hope Medical Center
2024-08-26 – 2027-01-24 · Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Breast Adenocarcinoma, Breast Ductal Carcinoma In Situ, Estrogen Receptor-Positive Breast Carcinoma, Progesterone Receptor-Positive Breast Carcinoma
What this study did
NCT06108349 · University of Virginia
2025-07-01 – 2027-01-01 · Carpal Tunnel Syndrome
What this study did
NCT06218056 · University of California, Los Angeles
2024-10-31 – 2026-12-31 · Tobacco Use Disorder, Tobacco Smoking, Tobacco Dependence
What this study did
NCT06672666 · University of Florida
2025-01-06 – 2026-12-31 · Anxiety, Generalized Anxiety Disorder, Sleep Problems
What this study did
NCT05457465 · Mclean Hospital
2023-06-01 – 2026-12 · Bipolar Disorder
What this study did
NCT06477406 · Mclean Hospital
2024-02-27 – 2026-12 · Endometriosis
What this study did
NCT06629389 · Laboratorio Elea Phoenix S.A.
2024-11-28 – 2026-11 · Parkinson Disease
What this study did
NCT03984565 · Staci Gruber, Ph.D.
2024-06-27 – 2026-11 · Chronic Pain
What this study did
NCT07570472 · KU Leuven
2026-03-19 – 2026-06-07 · Sleep Quality
What this study did
NCT04550377 · NYU Langone Health
2021-05-26 – 2026-06 · Post Traumatic Stress Disorder, Traumatic Brain Injury
What this study did
NCT05860699 · Assistance Publique - Hôpitaux de Paris
2024-04-08 – 2026-05-23 · Severe Alcohol Use Disorder (DSM 5)
What this study did
NCT06533657 · ZYUS Life Sciences Inc.
2025-06-12 – 2026-04-15 · Cancer Pain
What this study did
NCT07840924 · Wageningen University
2024-03-26 – 2026-03-28 · Sleep Quality, Multiple Sclerosis, Insomnia
What this study did
NCT05159830 · Hôpital le Vinatier
2024-10-25 – 2026-02-26 · Alcohol Use Disorder
What this study did
NCT05571592 · NYU Langone Health
2023-01-26 – 2025-12-03 · Social Anxiety Disorder
What this study did
NCT03518801 · VA Office of Research and Development
2019-10-01 – 2025-09-30 · PTSD
What this study did
NCT04821856 · Murdoch Childrens Research Institute
2021-05-11 – 2025-08-19 · Intellectual Disability, Child Behavior Problem
What this study did
NCT05299944 · University of Colorado, Denver
2022-03-08 – 2025-08-19 · Opioid Use Disorder
What this study did
NCT05632627 · University of Colorado, Denver
2023-04-11 – 2025-07-07 · Brain Injuries, Traumatic
What this study did
NCT02548559 · Staci Gruber, Ph.D.
2018-08-14 – 2025-03-13 · Anxiety
What this study did
NCT05753007 · Mclean Hospital
2024-02-15 – 2025-02-11 · Glioblastoma
What this study did
NCT05180240 · Cardiol Therapeutics Inc.
2022-07-28 – 2025-02-04 · Acute Myocarditis
What this study did
NCT04520685 · University of Colorado, Denver
2021-12-15 – 2024-12-31 · Autism Spectrum Disorder
What this study did
NCT07651930 · Medical University of Warsaw
2023-12-18 – 2024-11-17 · Parkinson's Disease (PD)
What this study did
NCT02088060 · Central Institute of Mental Health, Mannheim
2015-12-08 – 2024-09-16 · Schizophrenia
What this study did
NCT05494788 · Cardiol Therapeutics Inc.
2023-01-09 – 2024-09-06 · Recurrent Pericarditis
What this study did
NCT05317546 · Medical University of South Carolina
2022-10-01 – 2024-06-25 · Alcohol Use Disorder
What this study did
NCT05387148 · South West Sydney Local Health District
2022-06 – 2024-06 · Alcohol Use Disorder (AUD)
What this study did
Phase 1/2 (18)
Epilepsy
NCT02324673 · INSYS Therapeutics Inc
2015-04-13 – 2016-05-09 · Seizures
What this study did
Other / comorbidity
NCT06222268 · Leslie Lundahl
2026-09 – 2031-09 · PTSD, Post Traumatic Stress Disorder, Suicide, Cannabis Use
What this study did
NCT06381180 · Wayne State University
2025-09-22 – 2030-12-31 · Post Traumatic Stress Disorder, Cannabis Use, Suicide, Veterans, Marijuana
What this study did
NCT05885542 · Medical University of South Carolina
2023-11-01 – 2028-07-31 · Cannabis Use Disorder
What this study did
NCT06414473 · University of Florida
2024-06-14 – 2026-12-31 · Osteoarthritis, Knee
What this study did
NCT06099379 · Centre hospitalier de l'Université de Montréal (CHUM)
2024-06-27 – 2026-12-31 · Cannabis, THC
What this study did
NCT04726475 · University of Texas at Austin
2022-01 – 2024-01 · Anxiety and Fear
What this study did
NCT04760613 · NYU Langone Health
2022-02-03 – 2023-06-07 · Radiculopathy
What this study did
NCT04731116 · Rabin Medical Center
2021-01-10 – 2022-04-30 · COVID-19
What this study did
NCT03248167 · NYU Langone Health
2019-09-16 – 2022-04-20 · Alcohol Use Disorder, Post Traumatic Stress Disorder
What this study did
NCT03252756 · NYU Langone Health
2019-09-01 – 2022-03-16 · Alcohol Use Disorder
What this study did
NCT05498012 · Palacky University
2020-11-05 – 2022-02-01 · Chronic Periodontitis
What this study did
NCT03607643 · Leaf Vertical Inc.
2019-01-15 – 2020-12-15 · Cancer of Pancreas, Cancer of Liver, Cancer of Rectum, Cancer of Colon, Cancer, Gall Bladder, Myeloma Multiple, Glioblastoma Multiforme
What this study did
NCT03805750 · University of California, San Diego
2019-01-22 – 2020-11-30 · Essential Tremor
What this study did
NCT02751359 · University of California, Los Angeles
2016-07 – 2020-04 · Pain
What this study did
NCT01385124 · Rabin Medical Center
2012-09 – 2015-12 · Graft Versus Host Disease
What this study did
NCT01596075 · Rabin Medical Center
2012-07 – 2015-07 · Graft Versus Host Disease
What this study did
NCT01037322 · Meir Medical Center
2010-01 – 2012-09 · Crohn's Disease, Ulcerative Colitis
What this study did
Phase 1 (44)
Developmental and Epileptic Encephalopathies
NCT03467113 · Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
2018-01-19 – 2020-06-24 · Dravet Syndrome, Lennox Gastaut Syndrome
What this study did
Other / comorbidity
NCT07434895 · Hannah Harris
2026-08-05 – 2029-12-01 · Cannabis, Abuse Liability, Experimental Pain in Healthy Human Participants
What this study did
NCT06686914 · West Virginia University
2025-06-30 – 2029-05-01 · Cannabidiol Effects, Driving Performance
What this study did
NCT07167446 · Fox Chase Cancer Center
2025-10-14 – 2028-09-07 · Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients, Metastatic Colorectal Cancer (CRC), Peripheral Neuropathy Due to Chemotherapy
What this study did
NCT06692933 · Washington State University
2024-06-20 – 2027-12-31 · Interaction
What this study did
NCT05650697 · University of Oklahoma
2026-09 – 2027-12 · Forehead; Wound
What this study did
NCT05015439 · Johns Hopkins University
2023-04-20 – 2027-12 · Autism Spectrum Disorder
What this study did
NCT05445804 · Johns Hopkins University
2022-11-01 – 2027-02-01 · Tobacco Use, Tobacco Smoking, Tobacco Dependence, Tobacco Use Disorder, Tobacco Use Cessation
What this study did
NCT05283382 · University of Connecticut
2024-10-30 – 2027-02 · Anxiety and Fear
What this study did
NCT06617247 · University of Sao Paulo
2024-12-01 – 2026-12-31 · Burnout Syndrome
What this study did
NCT07027566 · Universidade Federal do Para
2025-07-25 – 2026-07 · Dentin Sensitivity
What this study did
NCT04883255 · University of California, San Diego
2023-05-03 – 2026-06-30 · HIV-1-infection
What this study did
NCT06695195 · Brent DeGeorge
2025-06 – 2026-03 · Upper Extremity Muscle Pain, Upper Extremity Bone Pain, Upper Extremity Pain
What this study did
NCT05934500 · Foundation for Orthopaedic Research and Education
2023-10-15 – 2025-12-30 · Post-operative Pain
What this study did
NCT06574100 · University of Saskatchewan
2024-10-26 – 2025-11 · Pharmacokinetics
What this study did
NCT06854783 · Tiamat Australia Pty Ltd
2025-07-14 – 2025-10-01 · Pharmacokinetics
What this study did
NCT02492074 · Central Institute of Mental Health, Mannheim
2024-12 – 2025-05 · Healthy Volunteers, Modeling Psychosis
What this study did
NCT05742724 · McMaster University
2024-01-11 – 2025-03-01 · Cannabis, Chronic Kidney Diseases, Dialysis
What this study did
NCT03877991 · Hadassah Medical Organization
2024-02-19 – 2025-02-19 · Pain
What this study did
NCT06123702 · Hartford Hospital
2024-04-30 – 2024-12-31 · Social Anxiety Disorder
What this study did
NCT03215940 · University of Utah
2018-02-01 – 2024-12-01 · Chronic Pain, Widespread
What this study did
NCT04044729 · University of Utah
2020-03-16 – 2024-12-01 · Chronic Pain
What this study did
NCT05232123 · Castleton University
2023-07 – 2024-12 · Healthy
What this study did
NCT05240755 · Foundation for Orthopaedic Research and Education
2022-07-01 – 2024-08-20 · Post-operative Pain
What this study did
NCT06137027 · The University of The West Indies
2023-09-21 – 2024-02-29 · Postoperative Nausea and Vomiting
What this study did
NCT04911127 · University of California, Los Angeles
2021-10-05 – 2023-12-31 · Rheumatoid Arthritis, Cannabis
What this study did
NCT05044936 · University of New Mexico
2023-05-15 – 2023-05-15 · Muscle Damage
What this study did
NCT04777643 · Yale University
2022-06-07 – 2023-04-27 · CBD, Neural Responses
What this study did
NCT05002114 · Louisiana State University Health Sciences Center Shreveport
2023-01 – 2023-01 · Musculoskeletal Joint Pain
What this study did
NCT04585841 · University of Copenhagen
2020-12-01 – 2022-11-01 · Lean Body Mass, Cannabis, Cancer, Nausea, Cachexia, Emesis, Appetitive Behavior
What this study did
NCT05346562 · University of Split, School of Medicine
2022-04-08 – 2022-10-05 · Hypertension
What this study did
NCT04349930 · University of New Mexico
2021-01 – 2022-09 · Interstitial Cystitis, Bladder Pain Syndrome
What this study did
NCT03634189 · Instituto de Cardiología y Medicina Vascular Hospital Zambrano-Hellion Tec Salud
2021-03-01 – 2021-12-01 · Heart Failure
What this study did
NCT04731779 · Castleton University
2021-08-30 – 2021-11-29 · Healthy
What this study did
NCT03295903 · University of British Columbia
2018-01-01 – 2021-10-01 · Diet Modification
What this study did
NCT04205682 · South West Sydney Local Health District
2020-01 – 2021-01 · Alcohol Withdrawal, Alcohol Dependence
What this study did
NCT05646459 · University of Nebraska
2020-05-14 – 2020-05-14 · Periodontitis, Adult, Inflammation Gum
What this study did
NCT03164512 · Johns Hopkins University
2018-06-01 – 2020-01-22 · Cannabidiol Pharmacokinetics
What this study did
NCT04193631 · Pure Green
2019-12-07 – 2019-12-09 · Musculoskeletal Pain
What this study did
NCT03471559 · Central Institute of Mental Health, Mannheim
2018-12-10 – 2019-08-29 · Pharmacokinetics, Bioavailability
What this study did
NCT02487381 · Central Institute of Mental Health, Mannheim
2015-04 – 2015-08 · Healthy, Modeling Psychosis
What this study did
NCT01893424 · Hadassah Medical Organization
2013-08 – 2015-01 · Pain
What this study did
NCT01180374 · Yale University
2010-02-01 – 2014-10-06 · Healthy
What this study did
NCT01311778 · Hurd,Yasmin, Ph.D.
2010-02 – 2011-10 · Opiate Addiction
What this study did
Phase 4 (3)
Other / comorbidity
NCT05022186 · Aristotle University Of Thessaloniki
2021-04-01 – 2022-12-20 · Mild Cognitive Impairment
What this study did
NCT04607603 · Medical University of Vienna
2020-10-13 – 2022-03-29 · Osteo Arthritis Knee, Pain, Joint
What this study did
NCT04396730 · Oregon Health and Science University
2020-04-08 – 2022-03-02 · Contraception
What this study did
Early phase / not applicable (26)
Other / comorbidity
NCT07271030 · London Metropolitan University
2026-01-16 – 2027-12 · Well-Being, Psychological, Quality of Life, Sexual Behavior, Sexual Pain Disorder
What this study did
NCT07821840 · Associação Pan-Americana Multidisciplinar de Endocanabinologia
2026-11-01 – 2027-04-01 · Generalized Anxiety Disorder
What this study did
NCT07910292 · Medical University of Silesia
2026-11 – 2027-03-30 · Healthy Aging, Cognition
What this study did
NCT07471347 · King's College London
2026-03 – 2026-12 · Cannabis Intoxication
What this study did
NCT05456113 · Penn State University
2024-12-01 – 2026-10-01 · Effect of Drug
What this study did
NCT07445568 · Universidad del Valle de México, Campus Cuernavaca
2025-09-01 – 2025-11-01 · Older Adults (60 - 85 Years Old), OA Knee
What this study did
NCT05892276 · University of Texas at Austin
2024-08-31 – 2025-08-31 · Posttraumatic Stress Disorder
What this study did
NCT07301658 · i+Med S.Coop.
2023-02-27 – 2024-08-07 · Atopic Dermatitis (AD)
What this study did
NCT05285449 · Christopher Bell
2022-02-09 – 2024-05-31 · Diabetes
What this study did
NCT06364254 · University of Northern Colorado
2023-11-11 – 2024-05-30 · Healthy
What this study did
NCT05774574 · Loughborough University
2023-01-20 – 2024-01-05 · Appetitive Behavior, Adverse Effect, Metabolic Health
What this study did
NCT04831294 · Auburn University
2021-07-15 – 2023-12-31 · CBD, Fear, Inhibition
What this study did
NCT06320327 · Joseph Pastina
2022-08-23 – 2023-04-30 · Muscle Soreness
What this study did
NCT06286839 · NextEvo Inc.
2022-05-12 – 2022-12-14 · Immune System and Related Disorders, Immune System Diseases
What this study did
NCT04881539 · University of Northern Colorado
2021-05-15 – 2022-03-18 · Healthy
What this study did
NCT06105138 · Colorado State University
2021-03-09 – 2022-03-03 · Alcohol Use Disorder
What this study did
NCT04971837 · Colorado State University
2021-05-20 – 2021-12-09 · Metabolism, Liver Function, Pharmacokinetics
What this study did
NCT04851392 · University College, London
2019-03-11 – 2021-06-16 · Cannabis, Cannabis Intoxication, Cannabis Use, Cannabis Dependence, Marijuana, THC, CBD, Adolescent Development
What this study did
NCT02932605 · UMC Utrecht
2017-11-03 – 2020-01-31 · Schizophrenia
What this study did
NCT05170217 · King's College London
2017-11-08 – 2019-06-09 · Cannabis Use
What this study did
NCT03537950 · King's College London
2016-08-22 – 2017-03-01 · Autism Spectrum Disorder
What this study did
NCT02902081 · University of Chicago
2013-02 – 2017-03 · Drug Addiction
What this study did
NCT02112292 · Wageningen University
2014-04 – 2015-04-16 · Sensory Science
What this study did
NCT02291536 · Central Institute of Mental Health, Mannheim
2014-02 – 2014-12 · Healthy Humans
What this study did
NCT02291562 · Central Institute of Mental Health, Mannheim
2014-07 – 2014-12 · Healthy Volunteers
What this study did

Competitive landscape

2 other tracked programmes target this mechanism, none of them ahead of this one.

This drug's own stage for Developmental and Epileptic Encephalopathies: Approved. Competitors below are sorted furthest-along first.

DrugStageModalityMechanismEvidence signalReported efficacygraded featured trials
Cannabidiol (Epidiolex): this drugApprovedSmall moleculeGPR55 / TRPV1 / adenosine transport (multi-target), cannabinoidReliable signal
NCT02091375: Percentage Change From Baseline In Convulsive Seizure Frequency During The Treatment Period (Baseline to End of Treatment (EOT) (Day 99) or Early Termination (ET)): GWP42003-P 20 mg/kg/Day Dose -38.94 percent change (IQR -69.53 to -4.83) vs Placebo -13.29 percent change (IQR -52.53 to 20.2)
Clobazam (Onfi)ApprovedSmall moleculeGABA-A receptorReliable signal
NCT00518713: Percent Reduction in Number of Drop Seizures (12-week Maintenance Period). (4-week baseline period and 12-week maintenance period): Clobazam Low Dose 41.2 Percent Reduction (range -119 to 100) | Clobazam Medium Dose 49.4 Percent Reduction (range -262 to 100) | Clobazam High Dose 68.3 Percent Reduction (range -39 to 100) vs Placebo 12.1 Percent Reduction (range -374 to 100)
Clobazam (Sympazan)ApprovedSmall moleculeGABA-A receptor (benzodiazepine site)not yet gradedNo reviewed efficacy summary in this indication
Fenfluramine (Fintepla)ApprovedSmall moleculeSerotonin 5-HT2 receptorsReliable signal
NCT03355209: Percentage change from baseline in drop-seizure frequency, fenfluramine 0.7 mg/kg/day (n=87) vs placebo (n=87): median reduction 26.5 vs 7.6 percentage points; estimated median difference -19.9 percentage points (95% CI -31.0 to -8.7; P=.001).
NCT02682927: Change From Baseline in the Mean Convulsive Seizures Frequency (MCSF) to the Combined Titration and Maintenance Periods (T+M) in Participants Receiving ZX008 0.8 mg/kg/Day Compared to Placebo (From Baseline up to 14 weeks [Titration Period (2 weeks) plus Maintenance Period (12 weeks)]): Study 1: ZX008 0.8 mg/kg/Day -13.11 seizure frequency per 28 days (Standard Deviation 25.5) | Study 3: ZX008 0.8 mg/kg/Day -3.54 seizure frequency per 28 days (Standard Deviation 124.132) vs Study 1: Placebo -6.71 seizure frequency per 28 days (Standard Deviation 24.263) | Study 3: Placebo 1.54 seizure frequency per 28 days (Standard Deviation 21.966)
GanaxoloneApprovedSmall moleculeGABA-A receptorPartial signal
NCT03572933: Median percentage change in 28-day major motor seizure frequency: ganaxolone -30.7% vs placebo -6.9% (p=0.0036); Hodges-Lehmann median difference -27.1% (95% CI -47.9 to -9.6), n=100 (Knight et al., Lancet Neurol 2022).
RufinamideApprovedSmall moleculeVoltage-gated sodium channelnot yet gradedNo reviewed efficacy summary in this indication
StiripentolApprovedSmall moleculeGABA-A receptorWeak signalNo reviewed efficacy summary in this indication
Vigabatrin (Sabril)ApprovedSmall moleculeGABA transaminase (GABA-T)not yet gradedNo reviewed efficacy summary in this indication
Vigabatrin (Vigafyde)ApprovedSmall moleculeGABA transaminase (GABA-T)not yet gradedNo reviewed efficacy summary in this indication
RelutriginePhase 3Small moleculeVoltage-gated sodium channel (persistent current)not yet gradedNo reviewed efficacy summary in this indication
BMB-101Phase 2Small moleculeSerotonin 5-HT2C receptor (biased agonist)not yet gradedNo reviewed efficacy summary in this indication

Upcoming events

(22 total)

Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.

Follow Cannabidiol (Epidiolex) to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.

Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

2026 (2)
December 2026 (2)
Phase 1/2Shoulder Osteoarthritis, Rotator Cuff InjuriesRecruiting
Est. primary completion 2026-12-30 · NCT06381791 · CT.gov ↗
What to watch
Phase 1Drug Drug InteractionNot yet recruiting
Est. primary completion 2026-12-31 · NCT07462559 · CT.gov ↗
What to watch
2027 (9)
February 2027 (1)
Phase 1/2Sickle Cell DiseaseRecruiting
Est. primary completion 2027-02-01 · NCT06930703 · CT.gov ↗
What to watch
March 2027 (2)
Phase 1Focal Onset SeizureNot yet recruiting
Est. primary completion 2027-03-15 · NCT07918469 · CT.gov ↗
What to watch
Phase 2Osteoarthritis, Knee, Osteoarthritis of the KneeRecruiting
Est. primary completion 2027-03-22 · NCT04992624 · CT.gov ↗
What to watch
April 2027 (1)
Phase 2/3Sanfilippo Syndrome, Mucopolysaccharidosis IIIRecruiting
Est. primary completion 2027-04 · NCT06333041 · CT.gov ↗
What to watch
May 2027 (1)
Phase 4Phobia, SocialRecruiting
Est. primary completion 2027-05 · NCT05649059 · CT.gov ↗
What to watch
August 2027 (2)
Phase 4EpilepsyActive not recruiting
Est. primary completion 2027-08-01 · NCT05044819 · CT.gov ↗
What to watch
Phase 3Generalized Anxiety Disorder (GAD), Anxiety DisordersRecruiting
Est. primary completion 2027-08-31 · NCT07123467 · CT.gov ↗
What to watch
November 2027 (1)
Phase 1EpilepsyRecruiting
Est. primary completion 2027-11-29 · NCT07233239 · CT.gov ↗
What to watch
December 2027 (1)
Phase 1Chronic Pain, Opioid Use DisorderRecruiting
Est. primary completion 2027-12-31 · NCT07886606 · CT.gov ↗
What to watch
2028 (7)
January 2028 (2)
Phase 4EpilepsyNot yet recruiting
Est. primary completion 2028-01-01 · NCT06924827 · CT.gov ↗
What to watch
Phase 2Breast Carcinoma, Chemotherapy-Induced Peripheral Neuropathy, Colon CarcinomaRecruiting
Est. primary completion 2028-01-07 · NCT06731894 · CT.gov ↗
What to watch
May 2028 (2)
Phase 2Supra-sacral Spinal Cord Injury, Spinal Cord Injury, Urinary IncontinenceRecruiting
Est. primary completion 2028-05 · NCT06840899 · CT.gov ↗
What to watch
Phase 3Opioid Use DisorderNot yet recruiting
Est. primary completion 2028-05 · NCT07148206 · CT.gov ↗
What to watch
July 2028 (1)
Phase 2Sturge - Weber Syndrome (SWS)Recruiting
Est. primary completion 2028-07 · NCT07778810 · CT.gov ↗
What to watch
December 2028 (2)
Phase 2Pain, ChronicRecruiting
Est. primary completion 2028-12 · NCT06213233 · CT.gov ↗
What to watch
Phase 4EpilepsyNot yet recruiting
Est. primary completion 2028-12-28 · NCT07728097 · CT.gov ↗
What to watch
2029 (3)
January 2029 (1)
Phase 2Knee Replacement Surgery, Osteoarthritis, KneeRecruiting
Est. primary completion 2029-01 · NCT06234631 · CT.gov ↗
What to watch
May 2029 (1)
Phase 2Neurodevelopmental Disorders With Severe Self-injuriesNot yet recruiting
Est. primary completion 2029-05 · NCT07564245 · CT.gov ↗
What to watch
September 2029 (1)
Phase 1CBD, Stress, Nicotine Dependence, Tobacco SmokingRecruiting
Est. primary completion 2029-09-01 · NCT07001930 · CT.gov ↗
What to watch
2030 (1)
February 2030 (1)
Phase 1/2Early Life Adversity, Trauma, StressRecruiting
Est. primary completion 2030-02-28 · NCT07278505 · CT.gov ↗
What to watch

See the full readout calendar ↗